Inventor · disambiguated record
Jeannette Whitcomb
Also filed as: WHITCOMB JEANNETTE · WHITCOMB JEANNETTE M
10 granted patents·9 pending applications·99 citations·filing 1995–2017
88Inventor score
Files withVIROLOGIC INC6MONOGRAM BIOSCIENCES INC4BEHRING DIAGNOSTICS GMBH1HUANG WEI1LABORATORY CORP AMERICA HOLDINGS1
Top patents by PatentIndex Score
19 records- 0186US7247439B1Method of evaluating a patient antibody response to envelope proteins of a virusMONOGRAM BIOSCIENCES INC·Filed 2002·Granted Jul 24, 2007·17 cites·31 claims
- 0285US6653081B2Methods for monitoring antiretroviral therapy and guiding therapeutic decision in the treatment of HIV/AIDSVIROLOGIC INC·Filed 2001·Granted Nov 25, 2003·17 cites·12 claims
- 0373US9841425B2Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assaysMONOGRAM BIOSCIENCES INC·Filed 2015·Granted Dec 12, 2017·1 cites·27 claims
- 0470US7579143B2Method of assessing the effectiveness of a non-nucleoside reverse transcriptase inhibitor (NNRTI) on a human immunodeficiency virus type 1 (HIV-1)-infected patientMONOGRAM BIOSCIENCES INC·Filed 2004·Granted Aug 25, 2009·1 cites·4 claims
- 0566US9581595B2Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapyHUANG WEI·Filed 2008·Granted Feb 28, 2017·2 cites·32 claims
- 0666US5750334ADetection of human papillomavirus mRNA in cervical smearsBEHRING DIAGNOSTICS GMBH·Filed 1995·Granted May 12, 1998·41 cites·4 claims
- 0763US9175355B2Methods for determining the presence of antibodies blocking viral infectionRICHMAN DOUGLAS·Filed 2009·Granted Nov 3, 2015·0 cites·23 claims
- 0863US2019025305A1Compositions and Methods for Evaluating Viral Receptor/Co-Receptor Usage and Inhibitors of Virus Entry Using Recombinant Virus AssaysMONOGRAM BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 0960US2004067487A1Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSVIROLOGIC INC·Filed 2003·Application pending·0 cites
- 1057US6489098B1Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSVIROLOGIC INC·Filed 1999·Granted Dec 3, 2002·17 cites·13 claims
- 1157US2005130134A1Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment HIV-AIDSVIROLOGIC INC·Filed 2004·Application pending·0 cites
- 1255US10358683B2Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapyLABORATORY CORP AMERICA HOLDINGS·Filed 2017·Granted Jul 23, 2019·0 cites·20 claims
- 1352US2004063191A1Compositions and methods for determining the replication capacity of a pathogenic virusFiled 2003·Application pending·0 cites
- 1448US2005214743A1Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assaysVIROLOGIC INC·Filed 2003·Application pending·0 cites
- 1548US2004110125A1Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assaysFiled 2002·Application pending·0 cites
- 1647US2008293038A1Method for Determining Resistance of Hiv to Nucleoside Reverse Transcriptase Inhibitor TreatmentPARKIN NEIL T·Filed 2006·Application pending·0 cites
- 1744US2002094522A1Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSFiled 2001·Application pending·0 cites
- 1837US7037644B1Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSVIROLOGIC INC·Filed 1999·Granted May 2, 2006·3 cites·19 claims
- 1930US2002034732A1Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screeningFiled 1998·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →